Mithra Pharmaceuticals SA

OTCPK:MITP.F Stock Report

Market Cap: US$236.6m

Mithra Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Leon Van Rompay

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.8yrs
CEO ownershipn/a
Management average tenure2.7yrs
Board average tenureless than a year

Recent management updates

Recent updates

CEO

Leon Van Rompay

1.8yrs

Tenure

Mr. Leon Van Rompay serves as Chief Executive Officer at Mithra Pharmaceuticals SA since February 2021. He founded Docpharma BVBA and serves as its Chief Executive of Docpharma BVBA. Mr. Van Rompay serves...

Leadership Team

NamePositionTenureCompensationOwnership
Leon Van Rompay
Chief Executive Officer1.8yrsno datano data
Christophe Marechal
Chief Financial Officer5.8yrsno datano data
Graham Dixon
Chief Scientific Officer3.4yrsno datano data
Benoit Mathieu
Group Investor Relations Manager1.8yrsno datano data
Cedric Darcis
Chief Legal Officerno datano datano data
Fanny Storms
Compliance Officerno datano datano data
Maud Vanderthommen
Group Communication Managerno datano datano data
Laurence Schyns
Chief Human Resources Officerno datano datano data
Jean-Manuel Fontaine
Chief Commercial & External Affairs Officer1.9yrsno data0.000050%
$ 118.3
Jean-Michel Foidart
President of the Scientific Advisory Board & Executive Directorno data€7.12k0.038%
$ 89.5k
Benjamin Brands
Chief Supply Chain Officer4.9yrsno datano data
Fanny Rozenberg
Secretary of the Boardno datano datano data

2.7yrs

Average Tenure

Experienced Management: MITP.F's management team is considered experienced (2.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jean-Michel Foidart
President of the Scientific Advisory Board & Executive Director6.3yrs€7.12k0.038%
$ 89.5k
Christian Moretti
Chairman of the Boardless than a year€10.42kno data
Gaetan Servais
Non-Executive Directorno data€25.00kno data
Valerie Gordenne
Non-Executive Directorless than a year€14.17k0.070%
$ 164.7k
Erik Van Eynden
Independent Vice Chairmanless than a year€25.00kno data
Patricia Dijck
Independent Directorless than a year€35.00kno data
Amel Tounsi
Non-Executive Directorless than a year€14.17kno data
Liesbeth Weynants
Independent Directorless than a year€11.67kno data
An Cloet
Independent Directorless than a year€11.67kno data

1.0yrs

Average Tenure

Experienced Board: MITP.F's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/12/05 05:33
End of Day Share Price 2022/09/07 00:00
Earnings2022/06/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mithra Pharmaceuticals SA is covered by 3 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Beatrice AllenBerenberg
Maxime StranartING Groep NV
Thomas LandemaineKepler Cheuvreux